The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.

The SARS-CoV-2 pandemic interrupted much respiratory research. Respiratory clinical academics joined colleagues in providing clinical care, and global research efforts were directed to finding new ...

In today's fast-paced world, many individuals struggle with respiratory issues, whether due to chronic conditions like asthma and COPD or temporary ailments such as colds and allergies. These problems ...